Cutaneous anthrax: A concise review

Cutis

Volumn 69, Issue 1, 2002, Pages 27-33

  Tutrone, William D ^a,b   Scheinfeld, Noah S ^a,c   Weinberg, Jeffrey M ^a,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Columbia University College of Physiciàns and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; DOXYCYCLINE;

ANTHRAX; BACTERIAL SKIN DISEASE; DRUG ADMINISTRATION; DRUG COMBINATION; HAND DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOLOGY; REVIEW; SKIN DISEASE;

ADMINISTRATION, ORAL; ANTHRAX; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FACIAL DERMATOSES; HAND DERMATOSES; HUMANS; INFUSIONS, INTRAVENOUS; SKIN DISEASES, BACTERIAL;

EID: 0036364698     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Heyworth B, Ropp ME, Voos UG, et al. Anthrax in the Gambia: an epidemiological study. J Hyg. 1975;54:79-82.
2. Collins CH. Laboratory Acquired Infections. 2nd ed. London, England: Butterworths; 1988:16.
3. Lalitha MK, Mathai D, Thomas K, et al. Anthrax - a continuing problem in Southern India. Salisbury Med Bull. 1996;87(suppl):14-15.
4. Quinn CP, Turnbull PCB. Anthrax. In: Collier L, Balows A, Sussman M, et al, eds. Topley and Wilson's Microbiology and Microbial Infections. 9th ed. Vol 3. London, England: Arnold; 1998:799-818.
5. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-1208.
6. Bowen JE, Turnbull PCB. The fate of Bacillus anthracis in unpasteurized and pasteurized milk. Lett Appl Microbiol. 1992;15:224-227.
7. Turnbull PCB, Bell RHV, Saigawa K, et al. Anthrax in wildlife in the Luangwa Valley, Zambia. Vet Rec. 1991;128:399-403.
8. Lindeque PM, Turnbull PCB. Ecology and epidemiology of anthrax in the Etosha National Park, Namibia. Onderstepoort J Vet Res. 1994;61:71-83.
9. VanNess GB. Ecology of anthrax. Science. 1971;172:1303-1307.
10. Leppla SH. The anthrax toxin complex. In: Alouf JE, Freer JH, eds. Sourcebook of Bacterial Protein Toxins. New York, New York: Academic Press; 1992:277-302.
11. Hammond SE, Hanna PC. Lethal factor active-site mutations affect catalytic activity in vitro. Infect Immun. 1998;66:2374-2378.
12. Duesbery NS, Webb CP, Leppla SH, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998;280:734-737.
13. Keppie J, Smith A, Harris-Smith PW. The chemical basis of the virulence of Bacillus anthracis, III: the role of the terminal bacteraemia in death of guinea-pigs from anthrax. Brit J Exp Pathol. 1955;36:315-322.
14. Office International des Epizooties (OIE). Animal Health and Disease Control Report 1997. Paris, France: Office International des Epizooties; 1997.
15. World Health Organization. Guidelines for the surveillance and control of anthrax in humans and animals. Bull World Health Organ. 1998;76.
16. World Health Organization. Anthrax control and research, with special reference to national programme development in Africa: memorandum from a WHO meeting. Bull World Health Organ. 1994;72:13-22.
17. Burnett JW. Anthrax. Cutis. 1991;48:113-114.
18. Walker DH, Yampoiska O, Grinberg LM. Death at Sverdlovsk: what have we learned. Am J Pathol. 1994;144:1135-1141.
19. Longfield R. Anthrax. In: Strickland GT, ed. Hunter's Tropical Medicine. Philadelphia, Pa: WB Saunders; 1991:434-438.
20. Brachman PS. Inhalation anthrax. Ann N Y Acad Sci. 1980;353:83-93.
21. LaForce FM. Anthrax. Clin Infect Dis. 1994;19:1009-1014.
22. Lakshmi N, Kumar AG. An epidemic of human anthrax: a study, Ind J Pathol Microbiol. 1992;35:1-4.
23. Kobuch E, Davis J, Fleischer K, et al. A clinical and epidemiological study of 621 patients with anthrax in westem Zimbabwe. Salisbury Med Bull. 1990;68(suppl):34-38.
24. Friedlander A, USAMRID Consortium. Post-exposure prophylaxis against experimental inhalation anthrax. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 29-October 2, 1991. Abstract 1194.
25. Doganay M, Aydin N. Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis. 1991;108:299-313.
26. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Mor Mortal Wkly Rep CDC Surveill Summ. 2001;50:909-919.
27. Notice to readers: update: recommendations for post-exposure prophylaxis and treatment of children and lactating women with Bacillus anthracis infections. Mor Mortal Wkly Rep CDC Surveill Summ. In press.